Cell Cycle Effects Resulting From Inhibition of Hepatocyte Growth Factor and Its Receptor C-Met in Regenerating Rat Livers by RNA Interference

Hepatology - United States
doi 10.1002/hep.21570
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Amplification and Overexpression of the Hepatocyte Growth Factor Receptor (HGFR/MET) in Rat DMBA Sarcomas

Oncogene
Cancer ResearchGeneticsMolecular Biology
1999English

C-Met Proto-Oncogene (MET; HGFR); Hepatocyte Growth Factor/Scatter Factor (HGF/SF)

Science-Business eXchange
2014English

Down-Regulation of MET, the Receptor for Hepatocyte Growth Factor

Oncogene
Cancer ResearchGeneticsMolecular Biology
2001English

PET of C-Met in Cancer With 64Cu-Labeled Hepatocyte Growth Factor

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2015English

Hepatocyte Growth Factor/C-Met Axis in Thyroid Cancer: From Diagnostic Biomarker to Therapeutic Target

Biomarker Insights
BiochemistryMolecular MedicinePharmacology
2017English

Hepatocyte Growth Factor/C-Met Signaling in Head and Neck Cancer and Implications for Treatment

Cancers
Cancer ResearchOncology
2017English

The Role of Egfr, Hepatocyte Growth Factor Receptor (C-Met), C-Erbb2 (Her2-Neu) and Clinicopathological Parameters in the Pathogenesis and Prognosis of Chordoma

Turk Patoloji Dergisi
Forensic MedicinePathology
2016English

Met/Hepatocyte Growth Factor Receptor Ubiquitination Suppresses Transformation and Is Required for HRS Phosphorylation

Molecular and Cellular Biology
Cell BiologyMolecular Biology
2005English

Targeted Inactivation of Hepatocyte Growth Factor Receptor C-Met in -Cells Leads to Defective Insulin Secretion and GLUT-2 Downregulation Without Alteration of -Cell Mass

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy